Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with alpha-galactosylceramide.

Source:http://linkedlifedata.com/resource/pubmed/id/20593019

Download in:

View as

General Info

PMID
20593019